Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Personalized Medicine|May 24, 2018
Individualizing analgesic prescription Part I: pharmacogenetics of opioid analgesicsCaroline Flora Samer, Jules Alexandre Desmeules, Pierre Dayer
Plos One|March 11, 2026
Potentially unsafe doses of local anesthetics in axillary brachial plexus block: A single-center retrospective cohort studyMélanie Suppan, Caroline Flora Samer, Georges Louis Savoldelli
Journal of Personalized Medicine|April 3, 2021
Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBaseSilvia Fernandez, Camille Lenoir, Caroline Flora Samer, et al.
Frontiers in Genetics|July 3, 2023
Polygenic risk scores in pharmacogenomics: opportunities and challenges-a mini reviewAurélien Simona, Wenyu Song, David W Bates, et al.
Current Drug Metabolism|February 15, 2014
Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a reviewVictoria Rollason, Caroline Flora Samer, Youssef Daali, et al.
Clinical and Translational Science|March 26, 2022
Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spotsGaëlle Magliocco, Jules Desmeules, Caroline Flora Samer, et al.
Clinical Pharmacology and Therapeutics|November 13, 2024
The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients: A Physiologically Based Pharmacokinetic Modeling StudyJean Terrier, Kenza Abouir, Frederic Gaspar, et al.
Current Drug Metabolism|July 17, 2015
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-ReviewYassine Bouatou, Caroline Flora Samer, Pierre Fontana, et al.
Pediatric Research|October 11, 2019
Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modelingGaëlle Magliocco, Frédérique Rodieux, Jules Desmeules, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Guidance on Selecting Optimal Steady-State Tacrolimus Concentrations for Continuous IV Perfusion: Insights from Physiologically Based Pharmacokinetic ModelingRomain Martischang, Argyro Nikolaou, Youssef Daali, et al.
Pageof 3